| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novavax Inc (NVAX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 92 sells. NVAX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 300.3K | $3.13M | - | |
| VP | 134.6K | $1.40M | - | |
| VP | 90.1K | $938.5K | - | |
| CFO | 86.3K | $899.6K | - | |
| Dir | 28.3K | $295.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 5,000 | $230.00 | $1,150,000.00 | -56.5% | -61.1% | -94.8% | |
| Dec 15, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 1,686 | $174.13 | $293,583.77 | -2.4% | -58.9% | -93.7% | |
| Dec 7, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 8,250 | $170.14 | $1,403,630.88 | -3.9% | -61.9% | -90.6% | |
| Dec 1, 2021 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 5,000 | $196.19 | $980,943.94 | -11.0% | -56.5% | -91.3% | |
| Nov 30, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 8,942 | $203.20 | $1,816,999.91 | -5.2% | -60.0% | -92.1% | |
| Nov 29, 2021 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 5,000 | $228.72 | $1,143,600.00 | -64.4% | -57.0% | -91.3% | |
| Nov 26, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 2,083 | $218.07 | $454,246.79 | -5.7% | -63.3% | -92.4% | |
| Nov 23, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 8,250 | $199.50 | $1,645,913.72 | -12.6% | -60.4% | -91.5% | |
| Nov 16, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 9,433 | $169.79 | $1,601,675.51 | -17.7% | -53.0% | -87.4% | |
| Nov 9, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 8,250 | $167.53 | $1,382,159.89 | -12.7% | -44.0% | -89.0% |